Atorvastatin

Atorvastatin is a statin, a medicine taken by mouth to lower LDL cholesterol. The FDA label says it is indicated to lower LDL cholesterol, as an adjunct to diet, in adults with primary hyperlipidemia. Lipitor is the brand name on the label read.

Also called Lipitor

  • Drug
  • In this atlas

Overview

Technical summary

RxNorm ingredient 83367; UNII 48A5M73Z4Q. The label names the substance as atorvastatin calcium trihydrate, so UNII 48A5M73Z4Q is the UNII of the salt form and is a broad match. MeSH descriptor D000069059 is Atorvastatin. Class: HMG-CoA Reductase Inhibitor (FDA established pharmacologic class, RxClass). The label read is the Viatris Specialty LLC label for LIPITOR (atorvastatin calcium), application NDA020702, effective 2024-04-15 in openFDA. This page records the label indication and the class only: no trial result and no dose is given.

Trials at a glance

The figures count the 81 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.

Trials
81
Phase 3 or 4
64
Recruiting
7
Regulatory decisions
0
Trials by phase (rows) and registry status (columns)
PhaseRecruitingNot yet recruitingActive, not recruitingCompletedTerminatedSuspendedUnknown statusAll statuses
Phase 21001101316
Phase 33102340334
Phase 43219101430
No phase00010001
All phases73144512081

Conditions these trials study

And 15 more.

Sponsors with the most trials

The lead sponsor of each trial, as the registry names it.

And 52 more.

About this drug

Level
Substance
Mechanism
Not reported

Classification codes

  • UNII 48A5M73Z4Q

Claims and evidence

Context People for whom the US label of atorvastatin lists an indication: adults with primary hyperlipidemia

Recipient
Adult
Population
Patients described in the indications section of the label, the passage read here being the adult LDL-cholesterol (LDL cholesterol) indication.
Care setting
Prescription medicine, as described in the US label
Geography
United States (label of the US Food and Drug Administration)
Life stage
Adults, as the passage read states
Follow-up
Not applicable (label statement)
Eligibility: 1 inclusion criterion; exclusion criteria not stated
Included
  • Adults with primary hyperlipidemia
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The US label of LIPITOR (atorvastatin calcium), in the Viatris Specialty LLC version dated 2024-04-15 in openFDA, lists the medicine to lower LDL cholesterol, as an adjunct to diet, in adults with primary hyperlipidemia.

    Applies to Adult People for whom the US label of atorvastatin lists an indication: adults with primary hyperlipidemia

    Certainty method
    Not assessed
    Limitations
    This claim records one thing the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label lists other indications that were not recorded; contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
    Last checked
    2026-11-07
    Next evidence check due
    Not scheduled
    Sources and citations (2)
    1. Supports openFDA drug label record for LIPITOR (atorvastatin calcium), Viatris Specialty LLC label: indications and substance identifiers

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id a60cc18b-0631-4cf0-b021-9f52224ece65 (manufacturer Viatris Specialty LLC, application NDA020702), returned on 2026-11-07. The label text is dated 2024-04-15 (effective_time). Other openFDA records of atorvastatin labels from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE
      How it applies
      The label sentence that gives the LDL-cholesterol indication.
      Retrieved
      Source effective date
      2024-04-15
      Source state
      Current
      Version fingerprint
      a862f32c454fe27cc452ac1f0bbb9931558c7eaeaa5a5e7c769d155d2001e6ea
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-07, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    2. Background openFDA drug label record for LIPITOR (atorvastatin calcium), Viatris Specialty LLC label: indications and substance identifiers

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id a60cc18b-0631-4cf0-b021-9f52224ece65 (manufacturer Viatris Specialty LLC, application NDA020702), returned on 2026-11-07. The label text is dated 2024-04-15 (effective_time). Other openFDA records of atorvastatin labels from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20240415.
      Retrieved
      Source effective date
      2024-04-15
      Source state
      Current
      Version fingerprint
      a862f32c454fe27cc452ac1f0bbb9931558c7eaeaa5a5e7c769d155d2001e6ea
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-07, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 81

Record details

Record id
cardio:atorvastatin
Content hash
095e3a14c656da776c219dfbcd7a897d3bc52d88c8803ffb2a8d34c222fc153b